Clinical trial
Screening for HIV-Associated Anal Cancer
NCT00188292 · University Health Network, Toronto, Other · Completed
Key facts
| NCT number | NCT00188292 |
|---|---|
| Title | Screening for HIV-Associated Anal Cancer |
| Official title | Screening for HIV-Associated Anal Cancer |
| Acronym | TRACE |
| Lead sponsor | University Health Network, Toronto, Other |
| Collaborators | Ontario HIV Treatment Network Canadian Foundation for AIDS Research (CANFAR) |
| Status | Completed |
| Study type | Observational |
| Conditions | HIV Infections, Anal Cancer, Anal Dysplasia, Papillomavirus Infections |
| Enrollment | 401 |
| Start date | Aug 1, 2002 |
| Primary completion | Jun 1, 2012 |
| Completion | Jun 1, 2012 |
| First posted | Sep 16, 2005 |
| Last update posted | Mar 8, 2016 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: